MDLN · NASDAQ · STOCK
Medline (MDLN) Stock Analysis
$36.26
52W $31.49 – $50.88
52/100
$30.66B
42.2
-0.41
Is MDLN Bullish or Bearish?
Mixed.
Innellis AI committee rates Medline Inc. (MDLN) Watch with a composite score of 52/100
, based on 6 analysts with 33% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +7.78 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -12.22 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — 3 consecutive earnings beats -- consistent execution. Value Analyst remains cautious — p/e of 68.8 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 3 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 68.8 is expensive by classic value standards — Value
- Price-to-book of 5.0x prices in significant intangible value — Value
- RSI at 72 is in overbought territory — Technical
- Bollinger bandwidth of 17.3% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
52/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 86%
of 192 Healthcare peers
Value Analyst
bearish
25
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 68.8 is expensive by classic value standards
Growth Analyst
bullish
82
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 3 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 72 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 17.3% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 53.9 to 52.2.
- New bearish signals: 3 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
Analyst-level changes:
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: score 58->48 (-10); +1 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
71.9
Overbought
MACD Histogram
0.285
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$32.84
Resistance
$36.98
Bollinger %B
0.83
Inside Bands
Price vs Moving Averages
EMA 9
$35.45
Above
EMA 21
$34.94
Above
EMA 50
$35.37
Above
EMA 200
$38.54
Below
Fundamental Analysis
Valuation
61
Growth
92
Profitability
27
Financial Health
85
Cash Flow
70
Valuation
P/E Ratio
42.2×
P/B Ratio
2.69×
PEG Ratio
-1.40
Dividend Yield
0.00%
52W High
$50.88
52W Low
$31.49
Quality & Growth
ROE
1079.4%
ROA
301.2%
Gross Margin
2502.4%
Operating Margin
606.6%
Revenue Growth YoY
—
Debt / Equity
1.09
AI Fundamental Assessment
P/E ratio of 42.2 (rich relative to a 15-40x range); Price-to-book of 2.7x; PEG ratio of -1.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 10.8%; Return on assets of 3.0%; Net margin of 2.3%; Gross margin of 25.0%; Current ratio of 4.33 (healthy short-term liquidity); Debt-to-equity of 1.09; Free cash flow per share is positive (2.36); Most recent quarter beat estimates by 52.2%; 3 consecutive earnings beats; EPS growth accelerating (-23.3% -> +51.5% QoQ); Analyst estimates rising over recent quarters
Get the Full MDLN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →